SC 13G Filing

Company

RIGEL PHARMACEUTICALS INC

Filed

December 15, 2005

Accession Number

0000930413-05-008261

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →